Stockreport

Eserion down 14% premarket on lower Praluent pricing [Seeking Alpha]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF Eserion down 14% premarket on lower Praluent pricingEsperion (NASDAQ:ESPR) slips14% premarket on light volume on the heels of Regeneron (NASDAQ:REGN) and Sanofi's (NYSE: [Read more]